COMMUNIQUÉS West-GlobeNewswire

Zealand Pharma will attend the Kempen Life Science Conference on April 18, 2018 in Amsterdam
12/04/2018
Press release - No. 10 / 2018 Zealand Pharma will attend the Kempen Life Science Conference on April 18, 2018 in Amsterdam Copenhagen, April 12, 2018 - Mats Blom, Executive Vice President and Chief Financial Officer ( [...]
Infant Bacterial Therapeutics publishes Annual Report for 2017
12/04/2018
Today, Infant Bacterial Therapeutics AB (publ) publishes the Annual Report for the financial year 2017. The report is available on IBTs website under financial information http://ibtherapeutics.com/investors/financial- [...]
ERYTECH to Present Results from Phase I Trial of eryaspase in ALL and New Pre-clinical Data at AACR 2018
12/04/2018
LYON, France, April 12, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq: ERYP ) , a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug [...]
Sensorion reports full year 2017 results
12/04/2018
Increase in operating costs consistent with advancing clinical development of SENS-111 for acute unilateral vestibulopathy (severe vertigo) and SENS-401 for sudden sensorineural hearing loss; Validating deal to study [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
12/04/2018
REGULATED INFORMATION GHENT, Belgium, 12 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
TiGenix reports 2017 full year results
12/04/2018
PRESS RELEASE Regulated information inside information TiGenix reports 2017 full year results Leuven (BELGIUM) - April 12, 2018, 7:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical [...]
TiGenix présente ses résultats de l'an 2017
12/04/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS RÈGLEMENTÉES INFORMATIONS PRIVILÉGIÉES TiGenix présente ses résultats de l'an 2017 Louvain (BELGIQUE) - 12 avril 2018, 07h00 CEST - TiGenix NV (Euronext Brussels et NASDAQ : TIG), [...]
Sanofi to invest €350 million in Canadian vaccine facility
12/04/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi to invest €350 million in Canadian vaccine facility Expansion demonstrates company's commitment to innovation and leadership in global public health New [...]
Sanofi va investir 350 millions d'euros dans une unité de production de vaccins au Canada
12/04/2018
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi va investir 350 millions d'euros dans une unité de production de vaccins au Canada Un agrandissement qui illustre l'engagement de l'entreprise en [...]
Fagron realises organic turnover growth of 6.8%
12/04/2018
Regulated information Nazareth (Belgium) / Rotterdam (The Netherlands), 12 April 2018 Fagron realises organic turnover growth of 6.8% Key points Organic turnover growth in Europe, South America and North America. Europe [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
12/04/2018
REGULATED INFORMATION GHENT, Belgium, 12 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
argenx to receive third preclinical milestone payment from collaboration with LEO Pharma - Milestone associated with CTA approval for ARGX-112
12/04/2018
Breda, the Netherlands/Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe [...]
Atea Pharmaceuticals Reports Positive Proof of Concept Clinical Data With AT-527 for the Treatment of Chronic Hepatitis C
12/04/2018
AT-527 is a novel pan-genotypic purine nucleotide prodrug NS5B polymerase inhibitor which has been safe and well tolerated in this ongoing multiple part trial AT-527 exhibits potent antiviral activity in genotype (GT)- [...]
Novavax Prices Public Offering of Common Stock
12/04/2018
GAITHERSBURG, Md., April 11, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX ), a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases, today announced that it [...]
Genesis HealthCare Announces Planned Divestiture of Facilities in Texas
12/04/2018
KENNETT SQUARE, Penn., April 11, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (Genesis, or the Company) (NYSE: GEN ), one of the largest post-acute care providers in the United States, today announced it has signed a [...]
VANC Announces Agreement for Acquisition of Corozon Platform
12/04/2018
VANCOUVER, British Columbia, April 11, 2018 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“ VANC ”) (TSXV:VANC) (OTCQB:NUVPF) is pleased to announce it has entered into a defintive agreement with Corozon Consulting [...]
Arbutus and Roivant Launch Genevant Sciences with Industry-Leading Platform to Develop Broad Range of RNA Therapeutics for Genetic Diseases
11/04/2018
Genevant aims to advance 5-10 product candidates into the clinic by 2020 across RNAi, mRNA, and gene editing modalities using Arbutus’ LNP and ligand conjugate platforms Genevant will be led by Executive Chairman Paris [...]
Extendicare Completes Acquisition of Lynde Creek Retirement Community
11/04/2018
MARKHAM, Ontario and ETOBICOKE, Ontario , April 11, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) today announced that it has completed the previously disclosed acquisition from [...]
Bellicum Announces Clinical Hold Lifted on U.S. Studies of BPX-501
11/04/2018
HOUSTON, April 11, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]

Pages